Soulmaz Fazeli Farsani

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Cross Sectional

Prognostic Factors

Top Venues

Journal of comparative effectiveness research

Pharmacoepidemiology and drug safety

Pediatric diabetes

This page only lists publications with an associated author ORCID identifier.

Publications

Soulmaz Fazeli Farsani, Kristy Iglay, Ling Zhang, Christian Niyonkuru, Laurieann Nessralla, Cynthia J Girman
Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post-authorization safety study. Pharmacoepidemiology and drug safety 33 (5) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Soulmaz Fazeli Farsani, Kristy Iglay, Ling Zhang, Christian Niyonkuru, Laurieann Nessralla, Cynthia J Girman
Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post-authorization safety study. Pharmacoepidemiology and drug safety 33 (5) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Dana Y Teltsch, Soulmaz Fazeli Farsani, Richard S Swain, Stefan Kaspers, Samuel Huse, Christina Cristaldi, Beth L Nordstrom, Kimberly G Brodovicz
Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data. Pharmacoepidemiology and drug safety 28 (2) (2019)
Soulmaz Fazeli Farsani, Heshu Abdullah-Koolmees, Patrick C Souverein, Anthonius de Boer, Aukje K Mantel-Teeuwisse
Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study. Pediatric diabetes 19 (1) (2017)